EX-99.2 3 afl33124-fabdocument.htm EX-99.2 Document

FINAL                     5/1/2024
aflaclogoa01a01a01a33a.jpg

Financial Supplement
First Quarter 2024

This document is a statistical supplement to Aflac’s quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document.

The Company adopted the Financial Accounting Standards Board’s Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts, as clarified and amended by (i) ASU 2019-09 Financial Services - Insurance: Effective Date, and (ii) ASU 2020-11 Financial Services - Insurance: Effective Date and Early Application (collectively, “LDTI”) as of January 1, 2023. The amended guidance is applied as of the beginning of the earliest period presented in the Company’s quarterly and annual financial statements, which results in a January 1, 2021 Transition Date. In conjunction with the adoption of LDTI, the Company changed its practice of recording the change in the deferred profit liability (DPL) on products with limited-payment features from the benefits and claims, net line item to the net earned premiums line item in the consolidated statement of earnings. This change in presentation has no impact on net earnings. All quarterly and annual amounts for 2021 and 2022 presented herein reflect these changes for LDTI and DPL.
For more information, contact:
David Young
Phone. 706.596.3264
Aflacir@aflac.com
investors.aflac.com



Aflac Incorporated and Subsidiaries
Share Data
(In Thousands)
BeginningShares IssuedShares PurchasedEndingQTD Weighted Avg. SharesYTD Weighted Avg. Shares
SharesStk. Bon.Stk. Opt.Treas.Misc.SharesAvg.DilutiveAvg.Avg.DilutiveAvg.
PeriodOutstanding& DRP& Misc.Shares
Purch.(1)
OutstandingSharesSharesDilutedSharesSharesDiluted
2022652,132 259 1,308 8,007 343 645,349 649,753 3,074 652,827 649,753 3,074 652,827 
645,349 269 101 11,185 634,526 640,707 2,536 643,243 645,205 2,805 648,010 
634,526 258 144 11,057 623,868 629,350 2,597 631,946 639,862 2,735 642,597 
623,868 222 120 8,938 16 615,256 619,845 3,149 622,994 634,816 2,839 637,655 
2023615,256 239 1,152 10,348 347 605,952 611,205 2,745 613,950 611,205 2,745 613,950 
605,952 259 225 10,461 595,969 600,742 2,187 602,929 605,945 2,466 608,411 
595,969 210 115 9,390 586,897 591,246 2,350 593,596 600,992 2,427 603,419 
586,897 191 94 8,698 578,479 581,876 3,005 584,881 596,173 2,572 598,745 
20241 578,479 212 1,320 9,276 457 570,278 574,886 2,596 577,482 574,886 2,596 577,482 
















(1) Includes previously owned shares used to purchase options (swapped shares) and/or shares purchased for deferred compensation program
2


Aflac Incorporated and Subsidiaries
Summary of Adjusted Results by Business Segment
(In Millions, except per-share data and where noted)
Years Ended December 31,3 Months Ended March 31,
%
2019202020212022202320232024Change
Aflac Japan$3,261 $3,263 $3,755 $3,281 $3,234 $788 $810 2.8 
Aflac U.S.1,272 1,268 1,356 1,359 1,501 352 356 1.1 
Corporate and other (1)
(72)(115)(293)(218)(425)(7)(3)
Pretax adjusted earnings4,461 4,416 4,819 4,422 4,310 1,133 1,163 2.6 
Income taxes (1)
1,147 864 893 808 577 180 202 12.2 
Adjusted earnings (2)
3,314 3,552 3,925 3,614 3,733 953 961 .8 
Reconciling items:
Adjusted net investment gains (losses)(15)(229)462 447 914 209 1,009 
Other and non-recurring income (loss) (3)
(1)(28)(73)39 — (2)
Income tax benefit (expense) on items excluded from adjusted earnings (4)
72 (83)357 (26)26 (89)
Tax reform adjustment (5)
— — — — —  
Tax valuation allowance release (6)
— 1,411 — — — —  
Net earnings$3,304 $4,778 $4,231 $4,418 $4,659 $1,188 $1,879 58.2 
Effective Tax rate25.7 %(14.9)%18.7 %9.3 %11.5 %11.5 %13.4 %
Earnings per share of common stock:
Net earnings (basic)$4.45 $6.69 $6.28 $6.96 $7.81 $1.94 $3.27 68.6 
Net earnings (diluted)4.43 6.67 6.25 6.93 7.78 1.94 3.25 67.5 
Adjusted earnings (basic) (2)
$4.46 $4.98 $5.83 $5.69 $6.26 $1.56 $1.67 7.1 
Adjusted earnings (diluted) (2)
4.44 4.96 5.80 5.67 6.23 1.55 1.66 7.1 
(1)
The change in value of federal historic rehabilitation and solar investments in partnerships of $32 and $51 for the three-month periods ended March 31, 2024, and 2023, respectively, is included as a reduction to net investment income. Tax credits on these investments of $33 and $52 for the three-month periods ended March 31, 2024, and 2023, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.
(2)
See non-U.S. GAAP financial measures for definition of adjusted earnings.
(3)
Foreign currency gains and losses for all periods have been reclassified from Other and non-recurring income (loss) to Net investment gains and losses.
(4)
Primarily reflects release of $452 in deferred taxes in 2022
(5)
The impact of Tax Reform was adjusted in 2018 for return-to-provision adjustments, various amended returns filed by the Company, and final true-ups of deferred tax liabilities. Further impacts were recorded in 2019 as a result of additional guidance released by the IRS.
(6)
Tax benefit recognized in 2020 represents the release of valuation allowances on deferred tax benefits related to foreign tax credits.
3


Aflac Incorporated and Subsidiaries
Consolidated Statements of Earnings - U.S. GAAP
(In Millions, except per-share data)
Years Ended December 31,3 Months Ended March 31,
%
2019202020212022202320232024Change
Revenues:
Net earned premiums
  Gross premiums$19,122 $18,955 $17,305 $15,025 $14,318 $3,738 $3,482 
  Assumed (ceded)(342)(333)(210)(124)(195)(50)(26)
    Total net earned premiums18,780 18,622 17,095 14,901 14,123 3,688 3,456 (6.3)
Net investment income3,578 3,638 3,818 3,656 3,811 943 1,000 6.0 
Net investment gains (losses) (1)
(135)(270)468 363 590 123 951 
Other income (1)
84 157 173 220 177 46 29 
     Total revenues22,307 22,147 21,554 19,140 18,701 4,800 5,436 13.3 
Benefits and Claims:
Benefits and claims, net
  Incurred claims -direct9,279 9,364 8,949 8,271 8,005 2,215 2,277 
  Incurred claims -assumed (ceded)(372)(296)(147)(108)(177)(41)(16)
  Increase in FPB (2)-direct
2,952 2,707 1,819 888 594 36 (195)
  Increase in FPB (2)-assumed (ceded)
83 21 51 172 (7) 
Total net benefits and claims, excluding
  reserve remeasurement
N/AN/A10,623 9,102 8,594 2,203 2,066 
Reserve remeasurement (gain) lossN/AN/A(147)(215)(383)(53)(56)
    Total net benefits and claims11,942 11,796 10,476 8,887 8,211 2,150 2,010 (6.5)
Acquisition and operating expenses:
   Amortization of DAC (3)
1,282 1,214 835 792 816 205 215 
   Insurance commissions1,321 1,316 1,256 1,117 1,052 280 255 
   Insurance expenses3,089 3,420 3,541 3,249 3,165 775 739 
   Interest expense228 242 238 226 195 48 47 
     Total acquisition and operating expenses5,920 6,192 5,870 5,384 5,228 1,308 1,256 (4.0)
     Total benefits and expenses17,862 17,988 16,346 14,271 13,439 3,458 3,266 (5.6)
     Pretax earnings4,445 4,159 5,208 4,869 5,262 1,342 2,170 
Income tax expense (benefit) (4)
1,141 (619)977 451 603 154 291 
     Net earnings$3,304 $4,778 $4,231 $4,418 $4,659 $1,188 $1,879 58.2 
(1) Foreign currency gains and losses for all periods have been reclassified from Other income to Net investment gains and losses for consistency with current period presentation.
(2) Future policy benefits
(3) Deferred acquisition costs
(4) Primarily reflects release of $452 in deferred taxes in 2022
4


Aflac Incorporated and Subsidiaries
Analysis of Net Earnings and Net Earnings Per Diluted Share
(In Millions, except for per-share data)
Other andForeign
NetOther and Non-ForeignNetNetNon-RecurringCurrency
NetInvestmentRecurringCurrencyEarningsInvestmentItemsImpact
PeriodEarnings
Gains (Losses) (1)
Items (1)(3)(4)
Impact (2)
Per Share
Gains (Losses) (1)
Per Share (1)(3)(4)
Per Share (2)
20193,304 (13)15 4.43 (.02).01 .02 
20204,778 (181)1,407 31 6.67 (.25)1.96 .04 
20214,231 365 (59)(42)6.25 .54 (.09)(.06)
20224,418 803 (262)6.93 1.26 — (.41)
20234,659 896 31 (113)7.78 1.50 .05 (.19)
202211,047 106 (1)(35)1.60 .16 — (.05)
21,394 448 — (59)2.17 .70 — (.09)
31,781 871 (97)2.82 1.38 — (.15)
4196 (621)— (70).31 (1.00)— (.11)
202311,188 235 — (41)1.94 .38 — (.07)
21,634 653 28 (25)2.71 1.08 .05 (.04)
31,569 472 (33)2.64 .80 — (.06)
4268 (464)— (14).46 (.79)— (.02)
202411,879 920 (2)(44)3.25 1.59  (.08)
(1) Items are presented net of tax.
(2) See non-U.S. GAAP financial measures for definition of adjusted earnings excluding current period foreign currency impact
(3) Foreign currency gains and losses and amortized hedge costs/income for all periods have been reclassified from Other income to Net investment gains and losses for consistency with current period presentation.
(4 )Tax benefit recognized in the third quarter of 2020 represents the release of valuation allowances on deferred tax benefits related to foreign tax credits.

5


Aflac Incorporated and Subsidiaries
Consolidated Balance Sheets
(In Millions, except per-share data)
December 31,March 31,
Assets:2019202020212022202320232024
Investments and cash:
Securities available for sale:
Fixed maturity securities available for sale, at fair value$86,950 $101,286 $94,206 $71,936 $69,578 $74,174 $66,452 
Fixed maturity securities available for sale - consolidated variable interest entities, at fair value4,312 4,596 4,490 3,805 3,712 3,925 3,678 
Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses30,085 24,464 22,000 19,056 17,819 18,936 16,689 
Equity securities, at fair value802 1,283 1,603 1,091 1,088 1,087 762 
Commercial mortgage and other loans, net of allowance for credit losses9,569 10,554 11,786 13,496 12,527 13,328 12,360 
Other investments1,477 2,429 3,842 4,070 4,530 5,241 6,677 
Cash and cash equivalents4,896 5,141 5,051 3,943 4,306 3,809 5,098 
   Total investments and cash138,091 149,753 142,978 117,397 113,560 120,500 111,716 
Receivables, net of allowance for credit losses (1)
816 778 672 647 848 789 1,038 
Accrued investment income772 780 737 745 731 701 693 
Deferred policy acquisition costs10,128 10,441 9,848 9,239 9,132 9,267 8,819 
Property and equipment, net581 601 538 530 445 528 418 
Other assets, net of allowance for credit losses (1)(2)
2,380 2,733 3,377 3,180 2,008 3,181 2,058 
Total assets$152,768 $165,086 $158,150 $131,738 $126,724 $134,966 $124,742 
Liabilities and Shareholders' Equity:
Liabilities:
Total policy liabilities$106,554 $114,391 $126,331 $96,910 $91,599 $99,933 $85,364 
Notes payable6,569 7,899 7,956 7,442 7,364 7,420 7,912 
Income taxes, primarily deferred5,370 4,661 30 698 154 647 777 
Other liabilities5,316 4,576 6,802 6,548 5,622 7,182 7,152 
Total liabilities123,809 131,527 141,119 111,598 104,739 115,182 101,205 
Shareholders' equity:
Common stock135 135 135 135 136 135 136 
Additional paid-in capital2,313 2,410 2,529 2,641 2,771 2,665 2,806 
Retained earnings34,291 37,984 40,963 44,367 47,993 45,555 49,872 
Accumulated other comprehensive income (loss):
Unrealized foreign currency translation gains (losses)(1,623)(1,109)(1,985)(3,564)(4,069)(3,618)(4,666)
Unrealized gains (losses) on fixed maturity securities8,548 10,361 9,602 (702)1,139 1,289 1,092 
Unrealized gains (losses) on derivatives(33)(34)(30)(27)(22)(26)(26)
Effect of change in discount rate assumption(s)N/AN/A(15,832)(2,100)(2,560)(4,894)(1,495)
Pension liability adjustment(277)(284)(166)(36)(8)(29)(7)
Treasury stock(14,395)(15,904)(18,185)(20,574)(23,395)(21,293)(24,175)
Total shareholders' equity28,959 33,559 17,031 20,140 21,985 19,784 23,537 
Total liabilities & shareholders' equity$152,768 $165,086 $158,150 $131,738 $126,724 $134,966 $124,742 
(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings or total shareholders' equity.
(2) Includes goodwill of $265 million in 2024, $270 million in 2023, $265 in 2022, $268 in 2021, $269 million in 2020 and $140 million in 2019
6


Aflac Incorporated and Subsidiaries
Quarterly Financial Results
(Dollars In Millions, except per-share data)
Total
NetNetBenefitsAcquisitionsTotalNet EPS
Adj. EPS (1)
EarnedInv.Total&&PretaxNetAdjusted
PeriodPremiumsIncomeRevenuesClaims, NetAdj. Exp.Earn.Earn.
Earn. (1)
BasicDil.BasicDil.
201918,780 3,578 22,307 11,942 5,920 4,445 3,304 3,314 4.45 4.43 4.46 4.44 
202018,622 3,638 22,147 11,796 6,192 4,159 4,778 3,552 6.69 6.67 4.98 4.96 
202117,095 3,818 21,554 10,476 5,870 5,208 4,231 3,925 6.28 6.25 5.83 5.80 
202214,901 3,656 19,140 8,887 5,384 4,869 4,418 3,614 6.96 6.93 5.69 5.67 
202314,123 3,811 18,701 8,211 5,228 5,262 4,659 3,733 7.81 7.78 6.26 6.23 
202214,079 903 5,173 2,483 1,396 1,294 1,047 942 1.61 1.60 1.45 1.44 
23,764 937 5,315 2,274 1,333 1,708 1,394 945 2.18 2.17 1.47 1.47 
33,535 920 4,704 2,076 1,299 1,329 1,781 910 2.83 2.82 1.45 1.44 
43,523 896 3,948 2,054 1,356 538 196 817 .32 .31 1.32 1.31 
202313,688 943 4,800 2,150 1,308 1,342 1,188 953 1.94 1.94 1.56 1.55 
23,573 999 5,172 2,098 1,249 1,825 1,634 954 2.72 2.71 1.59 1.58 
33,476 1,004 4,950 1,860 1,285 1,805 1,569 1,095 2.65 2.64 1.85 1.84 
43,385 865 3,777 2,103 1,385 289 268 732 .46 .46 1.26 1.25 
202413,456 1,000 5,436 2,010 1,256 2,170 1,879 961 3.27 3.25 1.67 1.66 


















(1) See non-U.S. GAAP financial measures for definition of adjusted earnings.
7


Aflac Incorporated and Subsidiaries
Quarterly Book Value Per Share
(Dollars In Millions, except per-share data)
Adjusted BV
Adjusted BVPer Share Incl
EquityAOCIAdjusted BVPer Share InclForeign Currency
BV PerBV PerAdjusted BVPer ShareForeign CurrencyTranslation G/(L)
PeriodShareShare
Per Share (1)
% Change
Translation G/(L)(1)
% Change
201939.849.1030.748.9%28.5110.6%
202048.4612.9035.5615.7%33.9619.1%
202126.12(12.90)39.019.7%35.975.9%
202232.73(10.45)43.1810.7%37.393.9%
202338.00(9.54)47.5510.1%40.518.3%
2022127.21(13.09)40.3110.1%36.537.0%
230.82(11.00)41.8211.3%36.754.6%
331.97(12.03)44.0014.6%36.993.4%
432.73(10.45)43.1810.7%37.393.9%
2023132.65(12.01)44.6610.8%38.695.9%
234.30(12.31)46.6111.5%39.487.4%
338.63(9.81)48.4410.1%40.8010.3%
438.00(9.54)47.5510.1%40.518.3%
2024141.27(8.95)50.2212.4%42.048.7%














(1) See non-U.S. GAAP financial measures for definition of adjusted book value and adjusted book value including unrealized
foreign currency translation gains and losses.
8


Aflac Incorporated and Subsidiaries
Return on Equity
Year Ended December 31,3 Months Ended March 31,
20192020
2021 (4)
2022202320232024
U.S. GAAP ROE (1) - Net earnings
12.6 %15.3 %26.7 %23.8 %22.1 %23.8 %33.0 %
Impact of excluding unrealized foreign currency translation gains (losses)(1.0)(0.9)(1.7)(2.5)(3.1)(3.2)(5.1)
Impact of excluding unrealized gains (losses) on securities and derivatives3.6 6.2 10.7 4.1 0.2 0.2 1.3 
Impact of excluding effect on change in discount rate assumptionsN/AN/A(18.5)(8.2)(1.9)(3.1)(2.4)
Impact of excluding pension liability adjustment(0.1)(0.2)(0.2)(0.1)— —  
Impact of excluding AOCI2.5 5.1 (9.7)(6.8)(4.9)(6.1)(6.2)
U.S. GAAP ROE - less AOCI15.1 20.3 17.0 17.0 17.2 17.7 26.8 
Differences between adjusted earnings and net earnings (2)
— (5.2)(1.2)(3.1)(3.4)(3.5)(13.1)
Adjusted ROE - reported (3)
15.2 15.1 15.8 13.9 13.8 14.2 13.7 
(1)U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.
(2)See separate reconciliation of net income to adjusted earnings.
(3)See non-U.S. GAAP financial measures for definition of adjusted return on equity
(4)Return on equity calculations for 2021 use beginning retained earnings and accumulated other comprehensive income adjusted for the adoption of LDTI.
9


Aflac Incorporated and Subsidiaries
Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact (1)
(Diluted Basis)
Change
QTDYTDExcludingExcluding
ForeignForeignForeignForeign
AdjustedCurrencyCurrencyCurrencyCurrency
Period
EPS(1)
Growth
Impact(1)
Impact(1)
Impact(1)
Impact
2019$4.44 6.7 %N/A.02 $4.42 6.3 %
2020$4.96 11.7 %N/A.04 $4.92 10.8 %
2021$5.80 16.9 %N/A(.06)$5.86 18.1 %
2022$5.67 (2.2)%N/A(.41)$6.08 4.8 %
2023$6.23 9.9 %N/A(.19)$6.43 13.4 %
20221$1.44 .7 %(.05)(.05)$1.50 4.9 %
21.47 — (.09)(.15)1.56 6.1 
31.44 (8.3)(.15)(.30)1.59 1.3 
41.31 (.8)(.11)(.41)1.43 8.3 
$5.67 (2.2)%$6.08 4.8 %
20231$1.55 7.6 %(.07)(.07)$1.62 12.5 %
21.58 7.5 (.04)(.11)1.62 10.2 
31.84 27.8 (.06)(.17)1.90 31.9 
41.25 (4.6)(.02)(.19)1.28 (2.3)
$6.23 9.9 %$6.43 13.4 %
20241$1.66 7.1 %(.08)(.08)$1.74 12.3 %
$1.66 7.1 %$1.74 12.3 %
(1) See non-U.S.GAAP financial measures for definition of adjusted earnings and adjusted earnings excluding current period foreign currency impact
10


Aflac Incorporated and Subsidiaries
Composition of Invested Assets
(In Millions)
December 31,March 31,
2019202020212022202320232024
Fixed Maturity Securities(1)
$109,456 $116,056 $107,369 $94,525 $88,508 $94,242 $84,283 
Commercial mortgage and other loans, net of allowance for credit losses (1)
Transitional Real Estate (floating rate)5,450 5,231 5,246 6,455 5,998 6,635 5,964 
Middle Market Loans (floating rate)2,412 3,635 4,601 5,028 4,531 4,935 4,487 
Commercial Mortgage Loans1,707 1,688 1,854 1,775 1,697 1,457 1,634 
Other Loans— — 20 238 301 301 275 
Total Commercial mortgage and other loans, net of allowance for credit losses(1)
9,569 10,554 11,721 13,496 12,527 13,328 12,360 
Equity Securities, at FV through net earnings802 1,283 1,603 1,091 1,088 1,087 762 
Alternatives(2)
551 919 1,703 2,107 2,619 2,255 2,686 
Total Portfolio$120,378 $128,812 $122,396 $111,219 $104,742 $110,912 $100,091 
Unrealized Gains (Losses) on Invested Assets
(In Millions)
December 31,March 31,
2019202020212022202320232024
Fixed Maturity Securities
     Available For Sale - Gross Gains$12,266 $14,771 $13,566 $4,800 $6,050 $5,875 $6,038 
     Available For Sale - Gross Losses(375)(481)(239)(4,528)(3,449)(3,082)(3,502)
     Total Available For Sale11,891 14,290 13,327 272 2,601 2,793 2,536 
     Held to Maturity - Gross Gains7,519 5,935 4,869 2,154 1,838 2,680 1,556 
     Held to Maturity - Gross Losses(10)— — — — —  
     Total Held to Maturity$7,509 $5,935 $4,869 $2,154 $1,838 $2,680 $1,556 
Credit Ratings on Fixed Maturities
(At Amortized Cost)
December 31, March 31,
Credit Rating2019202020212022202320232024
AAA1.1 %1.0 %1.0 %1.6 %1.6 %1.7 %1.6 %
AA4.3 4.5 5.1 5.2 5.7 5.3 6.1 
A68.6 69.3 68.9 68.0 68.1 67.9 67.7 
BBB23.1 21.9 22.5 23.0 22.9 23.0 23.1 
BB or Lower2.9 3.3 2.5 2.2 1.7 2.1 1.5 
100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %100.0 %
(1) Presented at amortized cost, net of reserves beginning in 2020

(2) Presented at carrying value; includes asset classes such as private equity and real estate funds managed by Global Investments; excludes Corporate driven activity, policy loans, short-term investments, real estate owned assets and FHLB equity balances
11


Aflac Incorporated and Subsidiaries
Supplemental Investment Data by Segment
3 Months Ended
December 31,March 31,
2019202020212022202320232024
Aflac Japan:
   Invested assets (in millions)(1)
¥11,784,586 ¥11,936,087 ¥12,405,531 ¥12,617,181 ¥12,127,531 ¥12,534,653 ¥12,486,906 
   Return on average invested assets(2)
2.33 %2.38 %2.72 %2.78 %2.90 %2.57 %3.14 %
   Portfolio book yield at end of period(3)
2.64 %2.59 %2.60 %3.06 %3.18 %3.13 %3.24 %
   Total purchases for period (in millions)(3)
¥1,003,885 ¥714,124 ¥952,038 ¥716,964 ¥378,541 ¥159,440 ¥300,570 
   New money yield(3)(4)
3.83 %3.75 %3.50 %4.48 %5.18 %5.18 %5.57 %
Aflac U.S.:
   Invested assets (in millions)(1)
$14,036 $14,848 $15,841 $16,772 $17,075 $16,609 $17,171 
   Return on average invested assets(2)
5.70 %4.90 %4.87 %4.72 %4.88 %4.74 %4.87 %
   Portfolio book yield at end of period(3)
5.40 %5.18 %4.94 %5.39 %5.53 %5.46 %5.57 %
   Total purchases for period (in millions)(3)
$1,835 $1,050 $2,130 $1,701 $907 $242 $519 
   New money yield(3)(4)
4.51 %3.04 %3.41 %5.16 %7.56 %7.01 %6.66 %
Hedge Costs/Income Metrics (5)(6)
3 Months Ended
December 31,March 31,
2019202020212022202320232024
Aflac Japan:
FX hedged notional at end of period (in billions) - forwards (7)
$8.8 $6.0 $6.4 $4.1 $— $3.7 $ 
FX hedged notional at end of period (in billions) - put options9.2 13.1 11.6 13.5 24.7 9.8 24.7 
Amortized hedge costs for period (in millions)(257)(206)(76)(112)(157)(58)(6)
Corporate and Other (Parent Company):
FX hedged notional at end of period (in billions) - forwards (7)
$4.9 $5.0 $5.0 $5.0 $2.6 $5.0 $2.3 
FX hedged notional at end of period (in billions) - put options2.0 2.0 1.9 2.6 0.5 10.4  
Amortized hedge income (costs) for period (in millions)89 97 57 68 122 29 28 
(1) Invested assets, including cash and short term investments, are stated at amortized cost; except for equities, which are at fair value.
(2) Net of investment expenses and amortized hedge costs, year-to-date number reflected on a quarterly average basis
(3) Includes fixed maturity securities, commercial mortgage and other loans, equity securities, and excludes alternative investments in limited partnerships, and any impacts from hedging
     activities
(4) Reported on a gross yield basis; excludes investment expenses, external management fees, and amortized hedge costs
(5) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income. Further, the metrics in this table are split to show the hedging of the market value of a portion of the USD investments in Japan Segment’s "USD Program" in the "Japan Segment Portfolio Allocation by Currency" table on page 13 of this supplement as well as the corporate hedging activities at Aflac Incorporated
(6) Aflac Japan and the Parent Company utilize foreign currency forwards and options to hedge foreign currency exchange rate risk. The hedge cost/income on the table above reflects our FX forward protection of the hedged USD portfolio, and hedge costs on one sided options used as caps, and on tail-risk put options.
(7) Notional is reported net of any offsetting positions within Aflac Japan or the Parent Company, respectively.
12


Aflac Incorporated and Subsidiaries
Japan Segment Portfolio Allocation by Currency (1)
(Dollars In Millions, U.S. GAAP Basis)
December 31, 2023March 31, 2024
Amortized
Cost
(3)
Fair
Value
Amortized
Cost
(3)
Fair
Value
JGB$39,151 $40,222 $36,641 $37,170 
Other19,517 20,285 17,868 18,647 
Total yen denominated58,668 60,507 54,509 55,817 
USD Program23,384 25,254 24,986 27,053 
Other2,081 2,902 1,948 2,848 
US dollar denominated25,465 28,156 26,934 29,901 
Total$84,133 $88,663 $81,443 $85,718 
Distribution of Consolidated Fixed Maturities by Sector (2)
March 31, 2024
(In millions)
Amortized Cost (3)
% of
Total
Government and agencies$37,754 44.8 %
Municipalities2,392 2.8 
Mortgage- and asset-backed securities3,169 3.8 
Public utilities6,909 8.2 
Electric5,704 6.8 
Natural Gas665 .8 
Other540 .6 
Sovereign and supranational835 1.1 
Banks/financial institutions8,517 10.1 
Banking4,895 5.8 
Insurance1,816 2.2 
Other1,806 2.1 
Other corporate24,707 29.2 
Basic Industry2,121 2.5 
Capital Goods3,011 3.6 
Communications2,653 3.1 
Consumer Cyclical1,945 2.3 
Consumer Non-Cyclical5,740 6.8 
Energy2,195 2.6 
Other1,094 1.3 
Technology3,153 3.7 
Transportation2,795 3.3 
        Total fixed maturity securities$84,283 100.0 %
(1) The entire U.S. segment investment portfolio is U.S. dollar denominated.
(2)In the first quarter of 2023, the Utility/Energy subsector was combined with the Natural Gas subsector to better reflect the risk characteristics of those issuers and align more closely with industry
  benchmarks.
(3) Net of reserves
13


Aflac Incorporated and Subsidiaries
Long-Term Debt Data
Adjusted Leverage Ratios
(In Millions)
December 31,March 31,
2019202020212022202320232024
Notes payable$6,569 $7,899 $7,956 $7,442 $7,364 $7,420 $7,912 
50% of subordinated debentures and perpetual bonds(408)(432)(389)(337)(315)(335)(295)
Pre-funding of debt maturities(348)— — — (211)— (198)
Adjusted debt (1)
5,814 7,467 7,568 7,105 6,839 7,086 7,420 

Total Shareholders' Equity28,959 33,559 17,031 20,140 21,985 19,784 23,537 
Accumulated other comprehensive (income) loss:
Unrealized foreign currency translation (gains) losses1,623 1,109 1,985 3,564 4,069 3,618 4,666 
Unrealized (gains) losses on fixed maturity securities(8,548)(10,361)(9,602)702 (1,139)(1,289)(1,092)
Unrealized (gains) losses on derivatives33 34 30 27 22 26 26 
Effect on change in discount rate assumptions N/AN/A15,832 2,100 2,560 4,894 1,495 
Pension liability adjustment277 284 166 36 29 7 
Adjusted book value (1)
22,344 24,625 25,442 26,569 27,505 27,062 28,639 
Adjusted capitalization ex-AOCI(1)(2)
$28,565 $32,524 $33,398 $34,011 $34,658 $34,482 $36,353 
Adjusted debt to adjusted capitalization ex-AOCI20.4 %23.0 %22.7 %20.9 %19.7 %20.5 20.4 %
Adjusted capitalization(1)(3)
$26,665 $31,131 $31,247 $30,411 $30,581 $30,835 $31,680 
Adjusted debt to adjusted capitalization21.8 %24.0 %24.2 %23.4 %22.4 %23.0 23.4 %
Debt Maturities(4)
(In Millions)
March 31, 2024
≤ 1 year1 > 5 years5 > 10 years10 > 20 years20 years +Total
Senior Notes$— $1,813 $2,882 $1,074 $1,291 $7,060 
Subordinated debt— — — — 793 793 
Total$— $1,813 $2,882 $1,074 $2,084 $7,853 

(1) See non-U.S. GAAP financial measures for definition of: adjusted debt; adjusted book value; adjusted debt, including 50% of subordinated debentures and perpetual bonds; and adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment
(2) Adjusted capitalization ex-AOCI is the sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value
(3)Adjusted capitalization is sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment
(4) Debt maturity amounts do not include discounts, premiums, deferred charges, or capital lease obligations.
14


Aflac Incorporated and Subsidiaries

Insurer Financial Strength Ratings
AM BestMoody'sS&PJCRR&I
U.S. Operating Companies
Aflac of ColumbusA+Aa3A+AAAA
Aflac of New YorkA+_A+__
Continental American Insurance CompanyA+____
Japan Operating Company
Aflac Life Insurance Japan Ltd.A+Aa3A+AAAA
Bermuda Operating Company
Aflac Re Bermuda Ltd.___AA_
Issuer Credit Ratings
AM BestMoody'sS&PJCRR&I
Aflac Incorporated
Long-term Senior DebtaA3A-A+A+
Junior Subordinated Debta-Baa1BBB_A-
Aflac of Columbus
Long-term Senior Debtaa_A+AA_
Aflac Life Insurance Japan, Ltd.
Long-term Senior Debtaa_A+AA_
Subordinated Bonds___AA-_
The outlook for all ratings assigned by A.M. Best, S&P, Moody's and R&I is stable. The outlook for all ratings assigned by JCR is positive.

15


Aflac U.S.
Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
Years Ended December 31,3 Months Ended March 31,
%
2019202020212022202320232024Change
Revenues:
Net earned premiums
  Gross premiums$5,818 $5,762 $5,540 $5,467 $5,669 $1,420 $1,489 
  Assumed (ceded)(11)(4)73 103 (14)
    Total net earned premiums5,808 5,758 5,614 5,570 5,675 1,428 1,475 3.3 
Adjusted net investment income720 705 754 755 820 197 206 4.6 
Other income excl. realized foreign
     exchange gains (losses)22 102 121 161 128 35 18 
     Total adjusted revenues6,550 6,565 6,489 6,486 6,623 1,660 1,699 2.3 
Benefits and claims:
Benefits and claims, net
  Incurred claims -direct2,611 2,498 2,183 2,245 2,423 595 765 
  Incurred claims -assumed (ceded)(5)(1)89 104 17 (12)
  Increase in FPB -direct268 271 463 326 280 88 (41)
  Increase in FPB -assumed (ceded)(2)(3)(11)(5)(1)2 
Total benefits and claims, net, excluding
  reserve remeasurement
N/AN/A2,724 2,679 2,715 691 715 
 Reserve remeasurement (gain) lossN/AN/A(85)(124)(283)(40)(30)
        Total benefits and claims, net2,871 2,765 2,639 2,555 2,431 651 686 5.4 
Adjusted expenses:
Amortization of deferred policy
     acquisition costs573 570 442 455 490 119 132 10.9 
Insurance commissions590 576 550 553 561 142 141 (.7)
Insurance and other expenses1,244 1,386 1,502 1,564 1,640 395 384 (2.8)
Total adjusted expenses 2,407 2,532 2,494 2,573 2,691 657 658 
     Total benefits and adjusted expenses5,279 5,297 5,132 5,127 5,122 1,308 1,343 2.7 
     Pretax adjusted earnings$1,272 $1,268 $1,356 $1,359 $1,501 $352 $356 1.1 
16


Aflac U.S.
Balance Sheets
(In Millions)
December 31,March 31,
2019202020212022202320232024
Assets:
Investments and cash$16,141 $17,949 $18,324 $15,987 $16,718 $16,228 $16,667 
Receivables, net of allowance for credit losses (1)
650 667 574 584 688 720 710 
Accrued investment income174 172 169 184 183 177 186 
Deferred policy acquisition costs3,544 3,450 3,366 3,463 3,573 3,491 3,585 
Other assets (1)
436 626 758 784 698 769 703 
Total assets$20,945 $22,864 $23,191 $21,002 $21,861 $21,385 $21,850 
Liabilities and Shareholders' Equity:
Future policy benefits$9,404 $9,674 $14,212 $10,870 $11,234 $11,199 $10,913 
Policy and contract claims1,779 2,010 151 200 258 225 340 
Other policy liabilities111 126 119 117 107 118 113 
Deferred income taxes51 235 (328)(243)(311)(157)(223)
Other liabilities1,803 2,016 2,010 2,080 2,062 2,017 2,091 
Shareholders' equity7,796 8,803 7,027 7,978 8,510 7,984 8,617 
Total liabilities & shareholders' equity$20,945 $22,864 $23,191 $21,002 $21,861 $21,385 $21,850 
(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on
net earnings or total shareholders' equity.

17


Aflac U.S.
Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes
(Restated to conform to current classifications)
(Dollars In Millions)
NetTotalBenefits TotalPretax
Earned%Adjusted%Adjusted%&%%Adjusted%Adjusted%
PeriodPremiumsChangeNII ChangeRevenues ChangeClaims, NetChangeAmort.ChangeExpensesChangeEarn.Change
20195,808 1.8 720 (1.0)6,550 1.7 2,871 (.6)573 7.3 2,407 6.0 1,272 (1.0)
20205,758 (.9)705 (2.1)6,565 .2 2,765 (3.7)570 (.5)2,532 5.2 1,268 (.3)
20215,614 (2.5)754 7.0 6,489 (1.2)2,639 (4.6)442 (22.5)2,494 (1.5)1,356 6.9 
20225,570 (.8)755 .1 6,486 — 2,555 (3.2)455 2.9 2,573 3.2 1,359 .2 
20235,675 1.9 820 8.6 6,623 2.1 2,431 (4.9)490 7.7 2,691 4.6 1,501 10.4 
202211,413 (.6)184 4.5 1,639 .7 666 (4.3)114 2.7 640 6.7 333 .6 
21,394 (1.0)193 2.1 1,628 .1 658 (4.6)113 1.8 627 4.7 343 1.5 
31,375 (1.3)185 (3.1)1,598 (1.1)616 4.1 114 3.6 638 3.2 345 (14.8)
41,388 (.2)192 (2.5)1,621 .1 614 (7.0)115 4.5 667 (1.3)339 20.2 
202311,428 1.1 197 7.1 1,660 1.3 651 (2.3)119 4.4 657 2.7 352 5.7 
21,425 2.2 203 5.2 1,663 2.1 645 (2.0)120 6.2 648 3.3 369 7.6 
31,419 3.2 209 13.0 1,661 3.9 510 (17.2)122 7.0 674 5.6 478 38.6 
41,403 1.1 211 9.9 1,639 1.1 626 2.0 129 12.2 712 6.7 302 (10.9)
202411,475 3.3 206 4.6 1,699 2.3 686 5.4 132 10.9 658 .2 356 1.1 














18


Aflac U.S.
Operating Ratios
(Before Management Fee)
12-Mo. RollingTotal AdjustedCombinedPretax
PremiumTot. Ben./Amort./Expenses/Ratio/Profit
 Period
Persistency (1)
PremiumPremiumTotal Adj. Rev.Total Adj. Rev.Margin
201977.7 49.4 9.9 36.7 80.6 19.4 
202079.3 48.0 9.9 38.6 80.7 19.3 
202179.7 47.0 7.9 38.4 79.1 20.9 
202277.3 45.9 8.2 39.7 79.0 21.0 
202378.6 42.8 8.6 40.6 77.3 22.7 
2024 YTD78.7 46.5 8.9 38.7 79.0 21.0 
2022178.7 47.1 8.1 39.0 79.7 20.3 
278.1 47.2 8.1 38.5 78.9 21.1 
377.9 44.8 8.3 39.9 78.4 21.6 
477.3 44.2 8.3 41.1 79.1 20.9 
2023177.9 45.6 8.3 39.6 78.8 21.2 
278.2 45.3 8.4 39.0 77.8 22.2 
378.7 35.9 8.6 40.6 71.2 28.8 
478.6 44.6 9.2 43.4 81.6 18.4 
2024178.7 46.5 8.9 38.7 79.0 21.0 
(1) Includes Network Dental & Vision, Consumer Markets, and Group Premier Life, Absence Management, and Disability Solutions products
   beginning in the first quarter of 2021











19


Aflac U.S.
Aflac U.S. Sales Results
(Dollars In Millions)
Annl.New Annl.
Prem.%Prem.%
PeriodIn ForceChangeSalesChange
20196,301 1.1 1,580 (1.3)
20206,099 (3.2)1,093 (30.8)
20216,003 (1.6)1,278 16.9 
20225,967 (.6)1,483 16.1 
20236,161 3.3 1,558 5.0 
202215,942 (1.4)299 19.0 
25,926 (1.0)305 15.6 
35,889 (.7)334 11.8 
45,967 (.6)545 17.4 
202316,023 1.4 315 5.3 
26,064 2.3 324 6.4 
36,062 2.9 359 7.5 
46,161 3.3 559 2.6 
202416,211 3.1 298 (5.2)




20


Aflac U.S.
Aflac U.S. Product Mix
(New Annualized Premium Sales, Dollars in Millions)
% of% of% ofCritical% ofHospital% ofDental/% of
PeriodDisabilityTotalLife TotalAccident Total
Care(1)
TotalIndemnityTotalVisionTotalTotal
2019355 22.5 97 6.1 450 28.5 346 21.9 263 16.6 69 4.4 1,580
2020243 22.3 80 7.3 285 26.1 242 22.2 197 18.0 45 4.1 1,093
2021296 23.1 114 9.0 321 25.1 273 21.3 209 16.4 65 5.1 1,278
2022378 25.5 156 10.5 338 22.8 299 20.1 226 15.3 85 5.8 1,483
2023399 25.6 188 12.0 326 20.9 322 20.7 225 14.5 98 6.3 1,558
2022170 23.3 24 7.9 75 25.3 63 21.2 50 16.7 17 5.6 299
277 25.2 26 8.3 75 24.6 63 20.6 45 14.9 19 6.4 305
397 28.9 33 10.0 76 22.6 60 18.1 47 14.1 21 6.3 334
4135 24.9 73 13.4 112 20.5 112 20.6 84 15.4 28 5.2 545
2023179 25.2 26 8.3 74 23.5 64 20.5 50 15.9 21 6.6 315
280 24.8 35 10.7 73 22.4 66 20.4 46 14.3 24 7.4 324
3101 28.2 54 15.0 72 19.9 67 18.6 45 12.6 20 5.7 359
4139 24.8 73 13.0 107 19.2 124 22.2 83 14.9 33 5.9 559
2024169 23.0 32 10.8 67 22.5 66 22.1 45 15.1 19 6.5 298
Aflac U.S. Sales Force Data
 AverageProductivity
Weekly(Production/
Recruited AgentsProducerAvg. Weekly
PeriodCareerBrokerTotalEquivalentsProducers)
201915,227 3,603 18,830 8,184 193,120 
202011,826 1,861 13,687 5,918 184,706 
202110,641 5,445 16,086 5,993 213,235 
20229,550 1,500 11,050 6,186 239,786 
202310,103 1,463 11,566 6,239 249,663 
202211,987 455 2,442 6,061 49,322 
22,937 391 3,328 6,067 50,264 
32,358 339 2,697 6,010 55,599 
42,268 315 2,583 6,607 82,538 
202312,676 348 3,024 6,108 51,525 
22,801 399 3,200 6,196 52,361 
32,407 431 2,838 6,044 59,425 
42,219 285 2,504 6,608 84,645 
202412,330 346 2,676 5,800 51,432 

(1) Includes cancer, critical illness, and hospital intensive care products
21


Aflac Japan
Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
Years Ended December 31,3 Months Ended March 31,
%
2019202020212022202320232024Change
Revenues:
Net earned premiums
  Gross premiums¥1,450,586 ¥1,409,134 ¥1,290,527 ¥1,246,657 ¥1,212,654 ¥306,739 ¥296,056 
  Assumed (ceded)(57,974)(55,926)(50,864)(48,578)(84,838)(19,691)(26,197)
    Total net earned premiums1,392,612 1,353,208 1,239,663 1,198,079 1,127,816 287,048 269,859 (6.0)
Net investment income (1)
   Yen denominated142,473 138,397 138,513 149,449 138,073 34,749 34,351 (1.1)
   US$ denominated157,717 167,541 202,905 215,171 247,277 53,853 62,996 17.0 
Net investment income300,191 305,938 341,419 364,621 385,352 88,602 97,348 9.9 
Amortized hedge costs on foreign investments (2)
(28,938)(22,816)(8,391)(13,155)(19,773)(7,671)(796)(89.6)
Adjusted net investment income271,253 283,122 333,028 351,466 365,579 80,931 96,551 19.3 
Other income excl. realized foreign
currency gains (losses)4,869 4,497 4,512 4,442 4,720 1,166 1,183 
     Total adjusted revenues1,668,734 1,640,827 1,577,203 1,553,988 1,498,115 369,145 367,593 (.4)
Benefits and claims:
Benefits and claims, net
  Incurred claims -direct727,491 734,471 743,247 788,572 781,774 215,238 224,857 
  Incurred claims -assumed (ceded)(45,657)(37,806)(31,798)(36,141)(70,748)(16,877)(19,407)
  Increase in FPB -direct292,444 260,200 149,084 73,592 44,121 (7,011)(23,025)
  Increase in FPB -assumed (ceded)(6,497)(11,377)(11,425)(5,618)2,226 2,647 2,331 
   Total benefits and claims, net, excluding reserve
      remeasurement
N/AN/A849,108 820,405 757,373 193,997 184,756 
   Reserve remeasurement (gain) lossN/AN/A(6,879)(13,337)(13,072)(1,727)(3,883)
            Total benefits and claims, net967,782 945,487 842,229 807,068 744,301 192,270 180,873 (5.9)
Adjusted expenses:
Amortization of deferred policy
    acquisition costs77,286 68,818 43,131 44,123 45,840 11,281 12,289 8.9 
Insurance commissions79,661 79,036 77,449 73,482 68,751 18,215 16,988 (6.7)
Insurance and other expenses189,203 199,606 202,586 198,493 182,364 43,129 36,880 (14.5)
Total adjusted expenses346,150 347,460 323,166 316,097 296,955 72,625 66,157 
      Total benefits and adjusted expenses1,313,932 1,292,947 1,165,395 1,123,165 1,041,256 264,895 247,029 (6.7)
Pretax adjusted earnings¥354,802 ¥347,881 ¥411,808 ¥430,823 ¥456,859 ¥104,251 ¥120,564 15.6 
(1) Includes the net interest cash flows from derivatives associated with certain investment strategies
(2) See non-U.S. GAAP financial measures for the definition of amortized hedge costs/income
22


Aflac Japan
Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
Years Ended December 31,3 Months Ended March 31,
%
2019202020212022202320232024Change
Revenues:
Net earned premiums
  Gross premiums$13,304 $13,193 $11,765 $9,558 $8,649 $2,318 $1,992 
  Assumed (ceded)(532)(524)(463)(372)(602)(148)(176)
    Total net earned premiums12,772 12,670 11,301 9,186 8,047 2,170 1,816 (16.3)
Net investment income (1)
   Yen denominated1,307 1,296 1,262 1,140 985 263 231 (12.2)
   US$ denominated1,446 1,569 1,845 1,641 1,755 407 424 4.2 
      Net investment income2,753 2,865 3,107 2,782 2,739 669 655 (2.1)
Amortized hedge costs on foreign investments (2)
(257)(206)(76)(112)(157)(58)(6)(89.7)
Adjusted net investment income2,496 2,659 3,031 2,669 2,582 611 648 6.1 
Other income excl. realized foreign
currency gains (losses)45 42 41 35 35 9 
     Total adjusted revenues15,313 15,371 14,373 11,890 10,664 2,790 2,473 (11.4)
Benefits and claims
Benefits and claims, net
  Incurred claims -direct6,671 6,875 6,776 6,038 5,582 1,626 1,512 
  Incurred claims -assumed (ceded)(419)(354)(290)(275)(502)(127)(131)
  Increase in FPB -direct2,684 2,437 1,356 562 314 (52)(154)
  Increase in FPB -assumed (ceded)(60)(107)(104)(43)15 19 16 
Total benefits and claims, net, excluding reserve
      remeasurement
N/AN/A7,738 6,282 5,409 1,466 1,243 
Reserve remeasurement (gain) lossN/AN/A(62)(91)(96)(13)(26)
Total benefits and claims, net8,877 8,851 7,675 6,191 5,313 1,453 1,217 (16.2)
Adjusted expenses:
Amortization of deferred policy
    acquisition costs709 644 393 338 326 85 83 (2.4)
Insurance commissions 731 740 706 563 491 138 114 (17.4)
Insurance and other expenses1,734 1,873 1,843 1,517 1,299 326 248 (23.9)
Total adjusted expenses3,174 3,257 2,942 2,417 2,117 549 445 
     Total benefits and adjusted expenses12,051 12,108 10,618 8,609 7,430 2,002 1,663 (16.9)
     Pretax adjusted earnings$3,261 $3,263 $3,756 $3,281 $3,234 $788 $810 2.8 
(1) Includes the net interest cash flows from derivatives associated with certain investment strategies
(2) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income
23


Aflac Japan    

        
Balance Sheets
(In Millions)
December 31,March 31,
2019202020212022202320232024
Assets:
Investments and cash¥12,847,994 ¥13,080,154 ¥13,645,902 ¥12,777,746 ¥12,566,939 ¥12,976,202 ¥12,993,051 
Receivables, net of allowance for credit losses28,219 20,782 22,439 23,138 24,848 25,467 60,415 
Accrued investment income65,485 62,722 67,493 76,489 74,666 68,075 72,487 
Deferred policy acquisition costs721,341 723,579 745,510 766,506 788,394 771,279 792,504 
Other assets308,411 320,351 386,832 387,065 946,644 682,018 948,349 
   Total assets¥13,971,450 ¥14,207,588 ¥14,868,176 ¥14,030,944 ¥14,401,491 ¥14,523,041 ¥14,866,806 
Liabilities and Shareholders' Equity:
Future policy benefits¥8,924,868 ¥9,175,501 ¥11,755,704 ¥10,315,140 ¥10,444,044 ¥10,768,070 ¥10,299,213 
Policy and contract claims315,477 328,778 — 28 465 620 653 
Unearned premiums453,133 361,010 284,045 227,732 192,595 218,038 185,338 
Other policyholders' funds801,588 808,429 877,690 880,989 874,854 889,926 882,723 
Income taxes (prim. deferred)618,901 478,969 36,166 114,688 95,297 101,778 167,677 
Other liabilities357,135 253,219 502,633 575,554 576,879 694,739 796,972 
Shareholders' equity2,500,349 2,801,682 1,411,938 1,916,812 2,217,357 1,849,870 2,534,230 
   Total liabilities & shareholders' equity¥13,971,450 ¥14,207,588 ¥14,868,176 ¥14,030,944 ¥14,401,491 ¥14,523,041 ¥14,866,806 

24


Aflac Japan

        
        
Balance Sheets
(In Millions)
December 31,March 31,
2019202020212022202320232024
Assets:
Investments and cash$117,269 $126,378 $118,639 $96,290 $88,606 $97,178 $85,814 
Receivables, net of allowance for credit losses258 201 195 174 175 191 399 
Accrued investment income598 606 587 576 526 510 479 
Deferred policy acquisition costs6,584 6,991 6,482 5,776 5,559 5,776 5,234 
Other assets2,815 3,095 3,363 2,917 6,675 5,108 6,263 
   Total assets$127,523 $137,271 $129,266 $105,734 $101,541 $108,762 $98,189 
Liabilities and Shareholders' Equity:
Future policy benefits$81,461 $88,652 $102,206 $77,733 $73,638 $80,642 $68,022 
Policy and contract claims2,879 3,177 — — 4 
Unearned premiums4,136 3,488 2,470 1,716 1,358 1,633 1,224 
Other policyholders' funds7,316 7,811 7,631 6,639 6,169 6,665 5,830 
Income taxes (prim. deferred)5,650 4,630 314 781 619 681 1,088 
Other liabilities3,260 2,447 4,369 4,337 4,067 5,203 5,264 
Shareholders' equity22,820 27,068 12,276 14,528 15,687 13,935 16,757 
   Total liabilities & shareholders' equity$127,523 $137,271 $129,266 $105,734 $101,541 $108,762 $98,189 

25


Aflac Japan
Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes
(Yen In Millions)
NetTotalBenefitsTotalPretax
Earned%Adjusted%Adjusted%&%%Adjusted%Adjusted%
PeriodPremiumsChangeNII ChangeRevenues ChangeClaims, NetChangeAmort.ChangeExpenseChangeEarn. Change
20191,392,612 (1.1)271,253 2.2 1,668,734 (.6)967,782 (1.6)77,286 (1.5)346,150 1.6 354,802 .2 
20201,353,208 (2.8)283,122 4.4 1,640,827 (1.7)945,487 (2.3)68,818 (11.0)347,459 .4 347,881 (2.0)
20211,239,663 (8.4)333,028 17.6 1,577,203 (3.9)842,229 (10.9)43,131 (37.3)323,166 (7.0)411,808 18.4 
20221,198,079 (3.4)351,466 5.5 1,553,988 (1.5)807,068 (4.2)44,123 2.3 316,097 (2.2)430,823 4.6 
20231,127,816 (5.9)365,579 4.0 1,498,115 (3.6)744,301 (7.8)45,840 3.9 296,955 (6.1)456,859 6.0 
20221304,884 (2.8)79,042 5.9 385,000 (1.2)206,890 (4.0)10,886 3.3 77,095 (.8)101,015 4.7 
2302,213 (3.1)94,004 8.4 397,358 (.5)204,807 (3.7)10,964 2.5 79,022 (.3)113,529 5.5 
3293,667 (4.5)92,241 9.8 387,113 (1.4)196,121 (4.8)11,073 2.9 77,498 (4.0)113,494 7.4 
4297,315 (3.1)86,180 (1.7)384,517 (2.8)199,250 (4.3)11,201 .6 82,482 (3.5)102,785 .8 
20231287,048 (5.9)80,931 2.4 369,145 (4.1)192,270 (7.1)11,281 3.6 72,625 (5.8)104,251 3.2 
2283,377 (6.2)87,963 (6.4)372,544 (6.2)186,310 (9.0)11,359 3.6 72,808 (7.9)113,426 (.1)
3285,305 (2.8)98,866 7.2 385,363 (.5)185,855 (5.2)11,435 3.3 73,068 (5.7)126,440 11.4 
4272,085 (8.5)97,819 13.5 371,063 (3.5)179,866 (9.7)11,766 5.0 78,454 (4.9)112,742 9.7 
20241269,859 (6.0)96,551 19.3 367,593 (.4)180,873 (5.9)12,289 8.9 66,157 (8.9)120,564 15.6 




















26


Aflac Japan
Operating Ratios
(Before Management Fee)
12-Mo. RollingTot. Ben./Tot. Adj.CombinedPretax
PremiumTot. Ben./PremiumsAmort./Expenses/Ratio/Profit
 Period
Persistency(1)
Premium(3rd sector)PremiumTotal Adj. Rev.Total Adj. Rev.Margin
201994.469.559.35.520.778.721.3
202095.169.959.75.121.278.821.2
202194.367.958.73.520.573.926.1
202294.167.458.53.720.372.327.7
202393.466.056.24.119.869.530.5
2022194.367.958.53.620.073.826.2
294.367.858.53.619.971.428.6
394.366.859.43.820.070.729.3
494.167.057.73.821.573.326.7
2023193.967.057.73.919.771.828.2
293.865.756.24.019.569.630.4
393.565.154.84.019.067.232.8
493.466.156.24.321.169.630.4
2024193.467.057.54.618.067.232.8















(1) Premium persistency presented on a 12-month rolling basis for all periods, rather than year to date

27


Aflac Japan

Aflac Japan Sales Results
(Yen In Millions, unless otherwise noted)
Annl.Third Sector
Prem.New Annl.Total
In Force%Prem.%New Annual.%
Period(Billions)ChangeSalesChangePremium SalesChange
20191,489.3 (2.5)72,836 (18.0)79,697 (16.9)
20201,426.5 (4.2)45,110 (38.1)50,852 (36.2)
20211,360.6 (4.7)48,977 8.6 54,764 7.7 
20221,301.0 (4.4)47,998 (2.0)54,765 — 
20231,246.4 (4.2)52,234 8.8 60,730 10.9 
202211,345.6 (4.6)10,679 (19.0)11,925 (14.8)
21,332.0 (4.3)11,372 (6.2)12,731 (6.4)
31,315.7 (4.3)12,639 12.1 13,884 10.2 
41,301.0 (4.4)13,308 1.7 16,224 11.4 
202311,281.4 (4.8)10,952 2.6 13,213 10.8 
21,268.4 (4.8)13,964 22.8 16,112 26.6 
31,257.4 (4.4)13,606 7.7 15,600 12.4 
41,246.4 (4.2)13,711 3.0 15,805 (2.6)
202411,232.6 (3.8)10,767 (1.7)12,534 (5.1)

28


Aflac Japan
Aflac Japan Product Mix
(New Annualized Premium Sales, Yen In Billions)
% of% ofIncome   % ofChild   % of% ofOrdinary% of% of
PeriodCancerTotalMedicalTotalSupportTotalEndowmentTotalWAYSTotalLife OtherTotalOtherTotalTotal
201947.2 59.2 24.6 31.0 1.0 1.2 .2 .2 .4 .5 5.9 7.4 .4 .5 79.7 
202028.8 56.6 15.9 31.2 .5 1.0 .2 .4 .4 .7 4.8 9.5 .3 .6 50.9 
202127.0 49.2 20.4 37.2 .3 .5 .2 .3 .4 .8 4.9 9.0 1.6 3.0 54.8 
202230.9 56.5 14.6 26.6 .7 1.3 .2 .3 1.9 3.5 4.5 8.1 2.0 3.7 54.8 
202338.9 64.1 12.3 20.2 .3 .4 .2 .4 4.1 6.8 3.9 6.5 1.0 1.6 60.7 
202216.4 53.0 3.8 31.4 .1 1.1 .1 .3 .1 .7 1.1 9.0 .5 4.5 11.9 
26.8 53.4 3.8 29.9 .3 2.2 — .2 .1 .8 1.2 9.2 .6 4.3 12.7 
38.4 60.1 3.7 26.4 .2 1.2 — .2 .1 .6 1.0 7.7 .5 3.8 13.9 
49.5 58.2 3.4 20.8 .1 .8 .1 .4 1.6 10.1 1.1 7.2 .4 2.5 16.2 
202317.9 59.9 2.7 20.8 .1 .6 .1 .6 1.2 8.9 1.0 7.3 .2 1.9 13.2 
210.9 67.7 2.8 17.5 .1 .4 .1 .4 1.0 6.6 1.0 6.1 .2 1.3 16.1 
310.3 65.6 3.1 20.0 .1 .4 .1 .4 .9 6.0 .9 6.1 .2 1.5 15.6 
49.9 62.5 3.6 22.8 .1 .4 — .3 .9 6.0 1.1 6.6 .2 1.4 15.8 
202417.9 63.2 2.7 21.1  .3  .3 .7 5.3 1.0 8.1 .2 1.7 12.5 


















29



Aflac Japan

Aflac Japan Sales Force Data
Number of Agencies by TypeSales Contribution by Agency Type
Period Individual/ Independent CorporateAffiliated
Corporate
BankTotal Individual/ Independent CorporateAffiliated
Corporate
Bank
Licensed Sales
Associates
(1)
Recruited
Agencies
20197,683 1,343 367 9,393 45.7 50.0 4.3 109,265 77 
20207,231 1,312 361 8,904 52.3 42.6 5.1 111,886 48 
20216,779 1,283 360 8,422 51.1 43.7 5.2 111,854 62 
20226,159 1,239 359 7,757 49.5 46.5 4.0 110,259 38 
20235,751 1,203 360 7,314 46.7 50.0 3.3 113,010 24 
2024 YTD5,659 1,191 360 7,210 48.9 48.0 3.1 112,645 12 
202216,447 1,266 360 8,073 48.9 46.5 4.6 109,873 
26,335 1,255 359 7,949 48.4 48.1 3.5 110,096 12 
36,260 1,246 359 7,865 49.3 46.2 4.5 110,400 12 
46,159 1,239 359 7,757 51.2 45.4 3.4 110,259 
202316,056 1,232 359 7,647 50.9 45.4 3.7 109,769 
25,947 1,219 360 7,526 44.8 52.5 2.7 112,593 
35,843 1,211 360 7,414 44.4 51.9 3.7 112,795 
45,751 1,203 360 7,314 47.7 49.2 3.1 113,010 
202415,659 1,191 360 7,210 48.9 48.0 3.1 112,645 12 















(1) Excludes Dai-ichi Life, banks, Japan Post Group and Daido Life
30



Aflac Japan
Yen/Dollar Exchange Rates
Yearly
ClosingQtrCum%
Period
Rate(1)
AvgAvgChange
2019109.56 N/A109.07 1.2 
2020103.50 N/A106.86 2.1 
2021115.02 N/A109.79 (2.7)
2022132.70 N/A130.17 (15.7)
2023141.83 N/A140.57 (7.4)
20221122.39 116.18 116.18 (8.9)
2136.68 129.39 122.79 (12.2)
3144.81 137.08 126.65 (14.3)
4132.70 141.87 130.17 (15.7)
20231133.53 132.30 132.30 (12.2)
2144.99 137.53 134.97 (9.0)
3149.58 144.97 138.38 (8.5)
4141.83 148.11 140.57 (7.4)
20241151.41 148.67 148.67 (11.0)
(1) Closing rate is based on the latest available and published MUFG Bank Ltd. TTM mid-day exchange rate.
31


Corporate and Other

Statements of Pretax Adjusted Earnings
(Before Management Fee)
(In Millions)
Years Ended December 31,3 Months Ended March 31,
%
2019202020212022202320232024Change
Revenues:
Total net earned premiums$200 $194 $180 $145 $400 $91 $165 81.3 
Net investment income (1)
88 80 (73)30 (77)51 628.6 
    Amortized hedge income (2)
89 97 57 68 121 29 28 (3.4)
Adjusted net investment income 177 177 (16)98 44 36 79 119.4 
Other income15 13 11 24 15 3 50.0 
     Total adjusted revenues393 384 175 267 460 129 247 91.5 
Benefits and expenses:
Total net benefits and claims194 180 161 141 467 46 107 132.6 
Interest expense133 164 165 162 144 33 36 9.1 
Other adjusted expenses137 155 142 181 273 57 107 87.7 
     Total benefits and adjusted expenses464 499 469 485 885 136 250 83.8 
     Pretax adjusted earnings $(72)$(115)$(293)$(218)$(425)$(7)$(3)57.1 
(1)
The change in value of federal historic rehabilitation and solar investments in partnerships of $32 and $51 for the three-month periods ended March 31, 2024, and 2023, respectively, is included as a reduction to net investment income. Tax credits on these investments of $33 and $52 for the three-month periods ended March 31, 2024, and 2023, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.
(2)
See non-U.S. GAAP financial measures for the definition of amortized hedge cost/income


32


Non-U.S. GAAP Financial Measures

This document includes references to the Company’s financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company’s business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The Company defines the non-U.S. GAAP financial measures included in this document as follows:

Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.
Adjusted book value including unrealized foreign currency translation gains and losses is adjusted book value plus unrealized foreign currency translation gains and losses. Adjusted book value including unrealized foreign currency translation gains and losses per common share is adjusted book value plus unrealized foreign currency translation gains and losses at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value including unrealized foreign currency translation gains and losses, and its related per share financial measure, important as they exclude certain components of AOCI, which fluctuate due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measures for adjusted book value including unrealized foreign currency translation gains and losses and adjusted book value including unrealized foreign currency translation gains and losses per common share are total book value and total book value per common share, respectively.
Adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is adjusted book value plus unrealized foreign currency translation gains and losses and pension liability adjustment. The Company considers adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment important as it excludes certain components of AOCI, which fluctuates due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measure for adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is total book value.

Adjusted debt is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding 50% of subordinated debentures and perpetual bonds and all pre-funding of debt maturities. The Company considers adjusted debt important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt is notes payable.
Adjusted debt including 50% of subordinated debentures and perpetual bonds is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding pre-funding of debt maturities. The Company considers adjusted debt including 50% of subordinated debentures and perpetual bonds important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt including 50% of subordinated debentures and perpetual bonds is notes payable.
33


Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that are outside of management’s control because they tend to be driven by general economic conditions and events or are related to infrequent activities not directly associated with insurance operations. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest from derivatives associated with notes payable but excluding any non-recurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.
Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.
Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company's Japan segment or in Corporate and other. These amortized hedge costs/income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the contractual term of the derivative. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income.
Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.
Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.
Adjusted return on equity is adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of AOCI, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on average equity (ROE) as determined using net earnings and average total shareholders’ equity.

34